Xtant Medical Holdings, Inc.
AMEXXtant Medical Holdings delivered a guidance-beating Q1 result on Tuesday — then fell 3.6% on the day. That gap between a strong print and a weak stock reaction is the central tension this week. Revenue came in at $20.9M, topping the $20.2M consensus estimate. More notably, full-year 2026 sales guidance was lifted to $101M–$105M, above the prior $95M–$99M range and comfortably ahead…
XTNT short interest surges 126% in one day to 7,586 shares, though remains minimal at 0.005% of float.
Snapshot as of 28 Jun 2026
Xtant Medical Holdings delivered a guidance-beating Q1 result on Tuesday — then fell 3.6% on the day. That gap between a strong print and a weak stock reaction is the central tension this week. Revenue came in at…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for XTNT — free to start on ORTEX.
Sign up for free →Open XTNT on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live XTNT data →